Kalos Management’s Merck MRK Stock Holding History

Kalos Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-604	Closed	-$64.3K	–	279
2023 Q1	$64.3K	Buy	+604	New	+$65.2K	0.13%	80
2021 Q1	–	Sell	-11,153	Closed	-$865K	–	308
2020 Q4	$865K	Buy	11,153 +231	+2%	+$17.7K	0.37%	88
2020 Q3	$843K	Sell	10,922 -50	-0.5%	-$3.92K	0.38%	81
2020 Q2	$859K	Buy	10,972 +3	+0%	+$226	0.36%	87
2020 Q1	$814K	Buy	10,969 +550	+5%	+$43.2K	0.36%	84
2019 Q4	$833K	Sell	10,419 -96	-0.9%	-$7.88K	0.3%	98
2019 Q3	$850K	Hold	10,515	–	–	0.34%	90
2019 Q2	$846K	Buy	10,515 +2,374	+29%	+$182K	0.38%	73
2019 Q1	$646K	Sell	8,141 -2,461	-23%	-$184K	0.42%	68
2018 Q4	$726K	Buy	+10,602	New	+$748K	0.35%	80
2018 Q3	–	Sell	-10,602	Closed	-$663K	–	193
2018 Q2	$663K	Hold	10,602	–	–	0.3%	94
2018 Q1	$590K	Sell	10,602 -232	-2%	-$12.5K	0.35%	78
2017 Q4	$569K	Buy	+10,834	New	+$601K	0.27%	101
2015 Q4	–	Hold	0	–	–	–	219

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kalos Management's MRK Position: Q2 2023 in Review

Kalos Management sold out of Merck (MRK) in Q2 2023, closing a stake of 604 shares — an estimated $64.3K sold.

Kalos Management first reported a position in MRK in Q4 2017 and held it in 13 quarters. The position peaked at $865K in Q4 2020. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

Kalos Management reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
Kalos Management sold 604 Merck shares in Q2 2023, an estimated $64.3K.
Kalos Management first reported a position in Merck in Q4 2017 and held it in 13 quarters.
Kalos Management's Merck position peaked at $865K in Q4 2020.
3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.